Literature DB >> 28530252

New trends in rehabilitation of children with ENT disorders.

R Bovo1, P Trevisi1, E Zanoletti1, D Cazzador1, T Volo1, E Emanuelli1, A Martini1.   

Abstract

In the last 20 years, neonatal survival has progressively increased due to the constant amelioration of neonatal medical treatment and surgical techniques. Thus, the number of children with congenital malformations and severe chronic pathologies who need rehabilitative care has progressively increased. Rehabilitation programs for paediatric patients with disorders of voice, speech and language, communication and hearing, deglutition and breathing are not widely available in hospital settings or in long-term care facilities. In most countries, the number of physicians and technicians is still inadequate; moreover, multidisciplinary teams dedicated to paediatric patients are quite rare. The aim of the present study is to present some new trends in ENT paediatric rehabilitation. © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.

Entities:  

Keywords:  Aural atresia; Children; Choanal atresia; Cochlear implant; Laryngeal paralysis; Music; Rehabilitation; Sinusitis; Voice

Mesh:

Year:  2017        PMID: 28530252      PMCID: PMC5720863          DOI: 10.14639/0392-100X-1426

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  62 in total

Review 1.  Music-based training for pediatric CI recipients: A systematic analysis of published studies.

Authors:  K Gfeller
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2016-05-27       Impact factor: 2.080

2.  Adaptation and validation of the Italian Pediatric Voice Handicap Index.

Authors:  Antonio Schindler; Cristiana Tiddia; Chiara Ghidelli; Vincenza Nerone; Roberto Albera; Francesco Ottaviani
Journal:  Folia Phoniatr Logop       Date:  2010-08-05       Impact factor: 0.849

Review 3.  Clinical consensus statement: tracheostomy care.

Authors:  Ron B Mitchell; Heather M Hussey; Gavin Setzen; Ian N Jacobs; Brian Nussenbaum; Cindy Dawson; Calvin A Brown; Cheryl Brandt; Kathleen Deakins; Christopher Hartnick; Albert Merati
Journal:  Otolaryngol Head Neck Surg       Date:  2012-09-18       Impact factor: 3.497

4.  Trends in the management of pediatric chronic sinusitis: survey of the American Society of Pediatric Otolaryngology.

Authors:  Steven E Sobol; Daniel S Samadi; Ken Kazahaya; Lawrence W C Tom
Journal:  Laryngoscope       Date:  2005-01       Impact factor: 3.325

5.  Predictive factors for success after transnasal endoscopic treatment of choanal atresia.

Authors:  Natacha Teissier; Florentia Kaguelidou; Vincent Couloigner; Martine François; Thierry Van Den Abbeele
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-01

6.  Laryngotracheal aspiration: analysis of specific neuromuscular factors.

Authors:  D J Curtis; T Hudson
Journal:  Radiology       Date:  1983-11       Impact factor: 11.105

Review 7.  Pediatric stridor.

Authors:  Jonathan B Ida; Dana Mara Thompson
Journal:  Otolaryngol Clin North Am       Date:  2014-08-07       Impact factor: 3.346

8.  Single-stage choanal atresia repair in the neonate.

Authors:  Jodi D Zuckerman; Syboney Zapata; Steven E Sobol
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-10

9.  Contact laser surgery in treatment of vocal fold paralysis.

Authors:  R Saetti; M Silvestrini; M Galiotto; F Derosas; S Narne
Journal:  Acta Otorhinolaryngol Ital       Date:  2003-02       Impact factor: 2.124

10.  Inability of clinical history to distinguish primary snoring from obstructive sleep apnea syndrome in children.

Authors:  J L Carroll; S A McColley; C L Marcus; S Curtis; G M Loughlin
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

View more
  1 in total

1.  Hearing loss in very preterm infants: should we wait or treat?

Authors:  S Frezza; P Catenazzi; R Gallus; F Gallini; M Fioretti; R Anzivino; M Corsello; F Cota; G Vento; G Conti
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-08       Impact factor: 2.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.